FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and represents the use of a pharmaceutical composition containing, as an active ingredient, a peptide selected from a group consisting of pGlu-Asn-Trp-Lys(octanoyl)-OH (SEQ ID NO: 1), pGlu-Asn-Trp-Thr-OH (SEQ ID NO: 2) and pharmaceutically acceptable salts thereof, for the treatment of an inflammatory disease or disorder selected from the group consisting of an inflammatory disease or disorder of the eye, inflammatory disease or disorder of ear, inflammatory disease or disorder of lungs, inflammatory disease or disorder of intestine, or inflammatory autoimmune disease or disorder.
EFFECT: invention provides attenuation of expression of inflammatory and pro-inflammatory mediators by peptides designated ZEP3 and ZEP4.
16 cl, 17 dwg, 9 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES-DERIVATIVES IL-4 FOR MODULATION OF CHRONIC INFLAMMATORY RESPONSE AND TREATMENT OF AUTOIMMUNE DISEASES | 2009 |
|
RU2542375C2 |
| HUMANISED ANTIBODIES SPECIFIC FOR HSP65-DERIVED PEPTIDE-6, METHODS AND USES THEREOF | 2010 |
|
RU2596925C2 |
| BLOCKING OF INFLAMMATORY PROTEASES BY THETA-DEFENSINS | 2012 |
|
RU2652605C2 |
| METHODS OF DEPRESSING INFLAMMATION MEDIATOR RELEASE AND PEPTIDES APPLIED FOR THIS PURPOSE | 2007 |
|
RU2423376C2 |
| BINDING MEMBERS TO TNF-ALPHA | 2015 |
|
RU2706551C2 |
| METHODS AND COMPOSITIONS FOR AUTOIMMUNE AND INFLAMMATORY DISEASES TREATMENT | 2012 |
|
RU2639540C2 |
| RECOMBINANT PROBIOTIC BACTERIA | 2015 |
|
RU2723324C2 |
| CELLULAR SYSTEM FOR TARGETED DELIVERY OF A PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL | 2016 |
|
RU2771323C2 |
| APTAMERS SPECIFIC FOR TLR-4, AND USE THEREOF | 2015 |
|
RU2709718C2 |
| SPECIFIC ANTIBODIES TO ALPHA-ENOLASE AND METHOD OF USING IN IMMUNE DISEASES | 2014 |
|
RU2707812C1 |
